Cintia Piccina
Corporate Officer/Principal presso ADAPTIMMUNE THERAPEUTICS PLC
Patrimonio netto: 175 231 $ in data 30/04/2024
Profilo
Cintia Piccina is currently the Chief Commercial Officer at Adaptimmune Therapeutics Plc.
She started this position in 2024.
Prior to her current role, she held the same position at Adaptimmune Therapeutics Plc from 2022 to 2023.
Cintia also has experience as the SVP-Commercial Oncology & US General Manager at 2seventy Bio, Inc. and as the Chief Commercial Officer at AlloVir, Inc. In terms of education, Dr. Piccina holds a doctorate degree from the University of Sao Paulo and an MBA from Escola Superior de Propaganda e Marketing.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
ALLOVIR INC
0.13% | 03/07/2023 | 147 000 ( 0.13% ) | 117 600 $ | 30/04/2024 |
01/04/2024 | 326 154 ( 0.06% ) | 57 631 $ | 30/04/2024 |
Posizioni attive di Cintia Piccina
Società | Posizione | Inizio |
---|---|---|
ADAPTIMMUNE THERAPEUTICS PLC | Corporate Officer/Principal | 18/03/2024 |
Precedenti posizioni note di Cintia Piccina
Società | Posizione | Fine |
---|---|---|
ADAPTIMMUNE THERAPEUTICS PLC | Corporate Officer/Principal | 05/03/2023 |
ALLOVIR, INC. | Corporate Officer/Principal | - |
2SEVENTY BIO, INC. | Corporate Officer/Principal | - |
Formazione di Cintia Piccina
University of Sao Paulo | Doctorate Degree |
Escola Superior de Propaganda e Marketing | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
ADAPTIMMUNE THERAPEUTICS PLC | Health Technology |
2SEVENTY BIO, INC. | Health Technology |
ALLOVIR, INC. | Health Technology |
- Borsa valori
- Insiders
- Cintia Piccina